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Abstract 15 
We report a novel colorimetric biosensor based on non-aggregation Au@Ag 16 
core-shell nanoparticles to detect methamphetamine and cocaine. The biosensor 17 
consisted of a reporter probe (RP) that is a specific single-stranded DNA (ssDNA) 18 
sequence coated on Au@Ag nanoparticles, a capture probe (CP) conjugated with 19 
magnetic beads, and an illicit drug-binding DNA aptamer (Apt). Au@Ag 20 
nanoparticles were synthesized by seed growth and characterized by scanning electron 21 
microscope (SEM), high-resolution transmission electron microscopy (HR-TEM), and 22 
UV-vis spectra. Methamphetamine (METH) was used as an example to evaluate the 23 
feasibility of the biosensor and to optimize the detection conditions. We demonstrated 24 
that this sensing platform was able to detect as low as 0.1 nM (14.9 ng L-1) METH 25 
with a negligible interference from other common illicit drugs. Various concentrations 26 
of METH were spiked into urines, and the biosensor yielded recoveries more than 27 
83.1%. In addition, the biosensor also showed a high sensitivity to detect cocaine. 28 
These results demonstrated that the colorimetric sensor holds promise to be 29 
implemented as a visual sensing platform to detect multiple illicit drugs in biological 30 
samples and environmental matrices.  31 
Keywords: Au@Ag, Aptamer, Methamphetamine, Colorimetry, Illicit Drug 32 
1. Introduction 33 
Illicit drugs are widely abused and have become an increasing global concern [1-5]. 34 
The United Nations Office of Drugs and Crimes has recently reported that illicit drugs 35 
had been used by a total of 246 million people, around 5 % of the global population 36 
aged between 15 and 64 [2]. Among these illicit drugs, cocaine (COC) is the primary 37 
drug of concern in Latin America/Caribbean and the second most used illegal 38 
substance in both Europe and United States[2, 3]. Methamphetamine (METH) is the 39 
second most widely abused drug in the world [6]. METH abuse has increased 40 
dramatically in the past years particularly in certain regions. For example, crystalline 41 
METH seizure has increased from around 7 tons in 2010 to 14 tons in 2013 in East 42 
and Southeast Asia [2]. The abuse of illicit drugs may cause severe societal 43 
consequences, such as loss of lives and health of abusers, increased treatment costs, 44 
and higher incidence of crimes [1-5].  45 
The commercial analytical techniques include gas chromatography and high 46 
performance liquid chromatography-mass spectrometry [4, 5]. Although highly 47 
sensitive and selective, these techniques usually require expensive instruments and 48 
tedious sample pretreatment in laboratory such as solid phase extraction (SPE) or 49 
solid phase micro-extraction (SPME). Therefore, there is a great need to develop rapid, 50 
inexpensive, and sensitive tools to detect illicit drugs in order to monitor and control 51 
illicit drug abuse, preferably on the spot of sample collection.  52 
Compared to conventional methods, biosensors hold promise to overcome the 53 
drawbacks of conventional analytical methods. A biosensor is a small device with a 54 
biological receptor that generates a signal (electrochemical, optical, nanomechanical, 55 
mass sensitive, etc.) in the presence of an analyte. Biosensors have the great potential 56 
for rapid and on-site detection of analytes in body fluids and environment samples, 57 
due to ease for miniaturization and capability of measuring complex matrices with 58 
minimal sample preparation[7-9]. In the past few decades, biosensors have been 59 
developed to measure numerous analytes in various matrices, such as heavy metals 60 
[10, 11], small molecule [12, 13], targeted DNA[14], peptides[15], enzyme[16], 61 
protein[15, 17], antigen [18], biomarkers[7, 8] and even bacteria[19, 20].  62 
Aptamers have been attracted increasing attention as a biological receptor for 63 
biosensing, which is a sequence of oligonucleotides with high binding affinity and 64 
specificity to target utilizing the systematic evolution of ligands by exponential 65 
enrichment (SELEX) technology [21, 22]. Recently, efforts have been devoted toward 66 
the design of biosensors based on DNA aptamer for the detection of illicit drugs, 67 
especially for COC[23]. Most researchers use specific DNA aptamer to bind with 68 
COC, which  generates a signal (electrochemical [24], colorimetry [25], 69 
fluorescence[26], SERS[27], etc.) in the presence of COC due to the conformation 70 
changes of DNA aptamers. Mokhtarzadeh et al [3] reviewed recent advances and 71 
applications of COC aptamer-based biosensors and nano-biosensors, which mainly 72 
focused on fluorescence, colorimetric and electrochemical techniques for the 73 
detection of COC. Besides COC, few other illicit drugs were reported using sensing 74 
technology. Mohsen et al [28, 29] firstly developed an electrochemical impedance 75 
spectroscopic sensing for methamphetamine using a specific aptamer by SELEX. Shi 76 
et.al [30] developed a colorimetric and bare eye determination of urinary 77 
methylamphetamine based on aptamers and the salt-induced aggregation of 78 
unmodified gold nanoparticles. Yarbakht and co-workers [31] described the 79 
unmodified gold nanoparticles as a colorimetric probe for visual methamphetamine 80 
detection.  81 
Nano notable metals, especially gold nanoparticles, have been used increasingly for 82 
biosensing application owing to their facile preparation and excellent optical 83 
properties [32-34]. These properties are utilized to develop many analytical methods 84 
including colorimetry[35, 36], light scattering[37, 38], scanometry [39, 40], surface 85 
enhanced Raman scattering [41] and chemiluminescence[42, 43]. In particular, 86 
colorimetry has particular advantages such as simplicity, low cost, and amenability[35, 87 
44]. The nano gold (AuNPs)-based  colorimetric biosensor to detect oligonucleotides 88 
was first reported by Mirkin’s group [32]. In their system, 89 
dispersed oligonucleotide-modified AuNPs were assembled into aggregated 90 
polymeric networks via hybridization with complementary target sequences. An 91 
obvious change in the surface plasmon resonance (SPR) absorption peak between 92 
dispersed and aggregated AuNPs was observed, leading to a significant red-to-blue 93 
color change which could be easily visualized by naked eyes[32, 44]. However, the 94 
efficiency of this method to detect lower concentration of targets was limited by the 95 
aggregation induced sedimentation [44]. To achieve highly sensitive assay, novel 96 
structures of AuNPs have been synthesized [45-47], for example, Au–Ag core–shell 97 
plasmonic nanoparticles (PNPs) as molecular probes for the detection of sulfide. This 98 
colorimetric assay allows for a linear logarithmic dependence on sulfide 99 
concentrations from 50 nM to 100 μM [45]. Yan et al [46] designed a Au core-Ag 100 
shell nanostructures with embedding Cy5-labelled DNA aptamer to target 101 
chloramphenicol using surface-enhanced Raman scattering (SERS) for detection. This 102 
SERS-based sensor is able to detect as low as 0.19 pg mL-1 chloramphenicol. 103 
However, to our knowledge, Au–Ag core–shell plasmonic nanoparticles (PNPs) have 104 
not yet been used for illicit drug detection.  105 
In this paper, we developed a non-aggregated Au@Ag-based colorimetric strategy 106 
for illicit drugs detection using a reporter probe, capture probe and an aptamer. 107 
Au@Ag core-shell nanoparticles were synthesized by seeds growth to enhance SPR 108 
signal and detection sensitivity. The biosensor was optimized by varying the 109 
concentrations of magnetic beads and the aptamer, as well as the hybridization 110 
reaction time. Selectivity of the sensor was examined using 8 common illicit drugs 111 
other than METH. The optimized sensor was used to detect METH in urine specimens 112 
of drug addicts to evaluate recovery. This platform was also demonstrated to be 113 
capable of detection of other illicit drugs such as cocaine, indicating that it could be 114 
used as a generic approach for monitoring of illicit drugs.  115 
2. Materials and Methods 116 
2.1. Materials 117 
HAuCl4·3H2O and AgNO3 were purchased from Shanghai Chemical Reagent Co., 118 
Ltd. (Shanghai, China). Carboxyl-coated magnetic beads (1.05 μm DynabeadsTM 119 
MyOne™, 10 mg mL-1) were purchased from Invitrogen in Norway. Trisodium citrate 120 
was obtained from Sigma-Aldrich (USA). Oligonucleotide sequences showed in 121 
Table S1 were obtained from Sangon Biotech (Shanghai, China) Co. Ltd. and purified 122 
by HPLC. All illicit drugs and metabolites were purchased from Cerilliant (Round 123 
Rock, TX, USA). Urines of METH abusers were collected in Guangdong Province 124 
with the help of a local rehabilitation center. Urine sample collection and experiments 125 
were carried out in accordance with a protocol approved by the ethics committee of 126 
Peking University and with informed consent of the addicts. 0.22 µm membrane 127 
filters were purchased from ANPEL Laboratory Technologies (Shanghai, China) Inc. 128 
Ultra-pure water (18.2 MΩ) from a Millipore filtration system was used in all 129 
experiments. Following buffers were used: PB solution (10 mM phosphate sodium 130 
buffer solution, pH 7.4), PBS-T buffer (10 mM phosphate sodium buffer solution, pH 131 
7.4, 0.1 M NaCl, 0.05% tween-20), MES buffer (2-[N-morpholino]ethane sulfonic 132 
acid, 0.1 M, pH 4.8), and Tris buffer (2-amino-2-hydroxymethyl-1,3-propanediol, 50 133 
mM, pH 7.4).  134 
2.2. Synthesis of Au@Ag core-shell nanoparticles 135 
Gold nanoparticles were prepared by reduction of gold (III) chloride hydrate using 136 
trisodium citrate, following the procedure described in a previous publication[48] and 137 
with minor modifications. Briefly, 50 mL 0.01% (w/w) HAuCl4 was reduced by 750 138 
μL 1% (w/w) trisodium citrate solution at 100 °C under vigorous magnetic stirring for 139 
15-20 min until the solution turned to be light red. The prepared red AuNPs particles 140 
were used as seed particles. Then 600 μL of AgNO3 solution (0.5 %, w/w) was added 141 
to 100 mL boiling gold seed solution. Afterwards, 1 mL sodium citrate solution (1 %, 142 
w/w) was added dropwise as the reducing agent with stirring. The solution was boiled 143 
for 1 h and then cooled down to room temperature. The Au@Ag was characterized by 144 
Scanning Electron Microscope (SEM) (SIGMA, Germany), Transmissions Electron 145 
Microscope (TEM) (JEM-2100) and UV-vis spectrometer (Perk Elmer, USA), which 146 
confirms the successful synthesis of Au@Ag core-shell nanoparticles with a mean 147 
diameter of 40 nm.  148 
2.3. Preparation of reporter and capture probe 149 
The reporter probe was derived by modifying the synthesized Au@Ag core-shell 150 
nanoparticles with a RP DNA sequence that was partially complementary to the 151 
aptamer. The Au@Ag core-shell nanoparticles suspended in 5 ml PB buffer (pH 7.4, 152 
10 mM phosphate) were loaded with 15 nMthiol-functionalized reporter probes[49]. 153 
After 24 h, 2 M NaCl was added to the solution to generate an overall NaCl 154 
concentration at 0.05 M, and then increased to 0.1 M after standing for 8 h. Upon 155 
aging in 0.1 M salt for additional 40 h, the nanoparticles were isolated by 156 
centrifugation at 6500 rpm for 15 min and washed three times with PBS-T (pH 7.4, 10 157 
mM phosphate, 0.05% Tween-20). 158 
The capture reporter was super paramagnetic magnetic beads (MBs) with a 159 
carboxyl-modified coating, which were conjugated with the capture probe DNA using 160 
the protocol suggested by the manufacturer. Before immobilization, 2.5 mL of 161 
carboxylated magnetic beads were washed twice with 2.5 mL of MES buffer (100 162 
mM, pH 4.8) and then resuspended in 250 μL MES buffer (100 mM, pH 4.8). Next, a 163 
mixture of 36.2 nmol NH2-modified capture DNA and 36.2 μmol EDC•HCl in 100 μL 164 
MES buffer was added to the washed magnetic beads and incubated overnight with 165 
gently shaking at room temperature. Finally, the coated MBs were incubated with 50 166 
mM Tris buffer (pH 7.4) for 15 min at room temperature with gentle shaking to 167 
quench the remaining activated carboxylic acid groups. The coated magnetic beads 168 
were washed for three times with 2.5 mL Tris buffer and then re-suspended in 169 
hybridization buffer (PBS-T) and stored at 4°C for use. 170 
2.4. Elaboration of biosensors 171 
In this study, we try to develop a strategy for illicit drugs detection based on the 172 
non-aggregated Au@Ag. To explore the effectiveness of the strategy, a 173 
non-aggregated Au@Ag nanoprobes-based on METH was employed as a case study. 174 
METH (1 μM, 10 μL) was mixed with 10 μL METH aptamer (200 nM) solutions, 175 
followed by introducing 20μL PBS-T buffer. After incubation for half an hour, 5 μL 176 
CP (PBS-T buffer) and 50 μL RP (PBS-T buffer) were then added to the solution and 177 
allowed to hybridize under gently vortexing for 90 min. The total volume was 178 
increased to 100 μL in PBS-T buffer. After hybridization, the MBs with target-linked 179 
Au@Ag core-shell nanoparticles together with unreacted MBs were easily attracted to 180 
the bottom of the tube by applying a round magnet (diameter: 3 cm, thickness: 3 mm). 181 
After the separation, the SPR of the supernatant was measured by a Shimadzu 182 
UV-2550 with 80 μL quartz micro-cuvette. 183 
Control experiments were performed with following combinations: MBs + Au@Ag; 184 
MBs + Au@Ag + METH; MBs + Au@Ag + aptamer. In these experiments, each 185 
component was added at the same volumes and concentrations as in the presence of 186 
METH. The missing components were replaced by the PBS-T buffer to maintain a 187 
constant total volume (100 µL). 188 
2.5 Optimization of Biosensors 189 
The concentration of magnetic beads causes the change of the ratio between the 190 
capture probes and reporter probe, which has significant impacts on the sensitivity of 191 
the assay. In order to get the optimal concentration of magnetic beads, a series of MBs 192 
concentrations were tested in this experiment. The experimental process was the same 193 
as the control experimental procedure (MBs + Au@Ag + aptamer) mentioned above. 194 
The volume of MBs (10 mg/mL) was 0, 0.1 µL, 0.5 µL, 1, and 5µL.  195 
Hybridization reaction time is an important parameter for colorimetric biosensor. 196 
We examined the reaction time of the hybridization by recording the peak intensities 197 
of SPR signal. The experimental process was also the same as the control 198 
experimental procedure described above. SPR signals were recorded every 15 min 199 
from 0 to 105 min. 200 
The optimal concentration of METH aptamer was determined by measuring 201 
absorbance intensities at 400 nm. The biosensor was optimized using different 202 
concentrations of aptamer (0, 10 nM, 20 nM, 30 nM, 40 nM, 50 nM, and 60 nM), 203 
following the procedure for control experiments mentioned above.  204 
2.6 Evaluation of the analytical performance   205 
Under the optimized conditions, the sensitivity and linearity of the biosensor to 206 
detect METH were determined at METH concentrations from 0.50 nM to 200 nM.  207 
The selectivity of the biosensor was evaluated by other 8 common illicit drugs and 208 
metabolites, namely ketamine (KET), norketamine (NK), morphine (MOR), cocaine 209 
(COC), cathinone (CAT), methcathinone (MCAT), 3-trifluoromethyphenylpiperazine 210 
(BZP), and 4,4'- two amino two phenyl methane (MDA). The experiment procedure 211 
was same as above, except that METH was replaced by other illicit drugs or 212 
metabolites. A much higher concentration (1 μM) was used for other drugs and 213 
metabolites, whereas a METH concentration of 50 nM was used as control.  214 
2.7 Analysis of urine samples with biosensors 215 
To test the feasibility of detecting METH in biological samples, METH 216 
concentrations in urines were determined using the biosensor. An aliquot of 20µL of 217 
each urine samples were measured using our sensors after filtered with 0.22 µm 218 
membrane filters. The measured concentrations were compared with those determined 219 
from high performance liquid chromatography-tandem mass spectrometer 220 
(HPLC-MS/MS) used a UFLCXR-LC system (Shimadzu, Japan) with a Phenomenex 221 
Gemini C18 column (100 mm 2 mm, 3 µm) and an ABI 4000 triple quadrupole mass 222 
spectrometer (AB SCIEX, USA).  For HPLC-MS/MS analysis, the urine samples 223 
were first diluted by MeOH by a factor of 6, vortexed for 20s, and centrifuged for 1 224 
min at 13000 rpm. Aliquots of supernatants, added with deuterated internal standards 225 
analyzed following conditions described elsewhere[4, 5]. To examine the recovery of 226 
METH, one of the urine samples was spiked with three concentrations (10, 50, and 227 
100 nM). The METH concentrations in spiked samples were then determined using 228 
the biosensor.  229 
2.8 Cocaine detection with biosensors 230 
In order to explore the universal applicability of our proposed strategy, another 231 
widely-used illicit drug, cocaine, was detected with the same approach. The detection 232 
followed the conditions for METH except with minor changes as follows: 1) the 233 
concentration of cocaine (COC) in the initial detection experiment and control 234 
experiment was 150 nM; 2) COC aptamer concentrations of 0, 5, 10,15, 20, 30, 40, 235 
and 50 nM were tested to find the optimal concentration; 3) COC concentrations 0, 236 
0.5, 1.0, 5.0, 10.0, 20.0, 40.0, 60.0, 80.0, 100.0, and 150.0 nM were tested to examine 237 
the sensitivity and linearity of the biosensor. 238 
3. Results and discussion 239 
3.1 Characteristics of Au@Ag 240 
According to experimental results, a significant red-to-yellow color change 241 
between AuNPs and Au@Ag can be easily visualized by the naked eye. Figure 1A 242 
showed that the average diameter of Au@Ag core-shell nanoparticle was 243 
approximately 40 nm. However, the contrast of the shell-silver nano particles is 244 
different from that of the core-AuNP in HR-TEM image (Figure 1B). The analysis of 245 
the UV-vis spectra (Figure 1 C) from AuNPs and Au@Ag core-shell nanoparticles 246 
show that the absorption peak (λmax) shifted from 520 nm to 400 nm, indicating a blue 247 
shift. This is because AuNPs and Au@Ag have different frequencies of surface 248 
plasmon resonance (SPR) in spite of the same particle size. The shift in the SPR 249 
absorption peak between AuNPs and Au@Ag led to the significant red-to-yellow 250 
color change. The intensity of SPR signal from Au@Ag was much stronger than that 251 
from AuNPs even though at the same concentrations. Thus, Au@Ag is a better signal 252 
transducer compared to AuNPs.  253 
3.2 Feasibility of biosensor  254 
The designed mechanism of the new colorimetric sensor is illustrated in Scheme 1. 255 
The biosensor consisted of a reporter probe (RP) (Scheme 1A), a capture probe (CP) 256 
(Scheme 1B) and an aptamer (Apt). The reporter probe was derived by modifying the 257 
synthesized Au@Ag core-shell nanoparticles with a RP DNA sequence that was 258 
partially complementary to the aptamer (Scheme 1A). The capture reporter was super 259 
paramagnetic magnetic beads (MBs) with a carboxyl-modified coating, which can be 260 
functionalized with amine-modified oligonucleotides with 261 
1-ethyl-3-(3-dimethylaminopropyl) carbodiaimide hydrochloride (EDC•HCl) as the 262 
linker (Scheme 1B). The amine-modified oligonucleotides are able to fully match one 263 
portion of a target sequence but are different from the fragment complementary with 264 
RP DNA. And these MBs were attracted by an external magnetic field and facilitate 265 
the sample separation activated by an external magnetic field. As is shown in Scheme 266 
1C, the aptamer could bind to reporter probe and capture probe to form 267 
Au@Ag-DNA-MBs sandwich structure through hybridization. The double-stranded 268 
DNA (dsDNA) was composed of both RP DNA and CP DNA complementary to the 269 
different DNA aptamer fragment. When an external magnetic field is applied, the 270 
sandwich structure complex is removed from the suspension, which reduces the 271 
intensity of SPR signal from Au@Ag core-shell nanoparticles [50, 51]. In contrast, in 272 
the presence of the target drugs, aptamer binding to the two probes is prevented and 273 
Au@Ag-DNA-MBs complex cannot be formed the aptamer which binds preferably 274 
with the target drug molecules due to higher affinity [28, 29]. Thus, the concentration 275 
of Au@Ag remaining in the supernatant is proportional to the concentrations of target 276 
drugs. As the amount of the target drug increased, the color of the supernatant 277 
changed from light yellow to deep yellow, which could be measured with UV-vis 278 
spectrometer and even be visualized by naked eye. 279 
To test the feasibility of this strategy, effects of this analytical method with or 280 
without illicit drugs (e.g. METH) on the SPR signal of Au@Ag core-shell 281 
nanoparticles were determined. In the control experiment, an absolute absorbance 282 
intensity of 0.46 was observed (Figure 1D, MBs+Au@Ag). When METH was added 283 
to the system, the absorbance intensity has no significant change (Figure 1D, 284 
MBs+Au@Ag+METH), indicating that METH alone had no interference to this 285 
analytical system. When METH aptamer was added to the system, the absorbance 286 
intensity decreased dramatically (Figure 1D, MBs+Au@Ag+Apt), due to the 287 
formation of the Au@Ag-dsDNA-MBs complex following the base pair matching 288 
principle to form dsDNA. The Au@Ag-dsDNA-MBs sandwiches could be removed 289 
by external magnetic field. The removal of Au@Ag core-shell nanoparticles leaded to 290 
a decrease in absorbance signal at 400 nm. When both METH and METH aptamer 291 
existed in this system, the absorbance was basically recovered (Figure 1D, 292 
MBs+Au@Ag+Apt+METH). The signal was only slightly lower than the value of 293 
absolute absorbance intensity of Au@Ag core-shell nanoparticles. The increase in 294 
absorbance in the presence of both METH aptamer and METH was due to formation 295 
of METH-aptamer complex. The complex blocked formation of the 296 
Au@Ag-DNA-MBs complex, which prevented removal of the Au@Ag core-shell 297 
nanoparticles by the external magnetic field.  298 
According to our experimental results, (1) The color of the solution is always 299 
yellow and can only be reduced in magnitude in the presence of different 300 
concentration of METH (Figure 3C); (2) There is no complex spectrum in the 301 
presence of different concentration of METH (Figure 3A); (3) The peak of SPR signal 302 
is always at 400 nm, thus, there is no red shift or blue shift (Figure 3A). Thus, on this 303 
sensing platform, Au@Ag core-shell nanoparticles would bind specifically with 304 
magnetic particles without the formation of the Au@Ag aggregates. This simple 305 
design avoids the complex spectrum of the classical colorimetric biosensor based on 306 
nanoparticles aggregation[6]. The color of the solution is always yellow and can only 307 
be reduced in magnitude. Due to the stability of dispersed Au@Ag core-shell 308 
nanoparticles, one only needs to examine the change in intensity of their specific 309 
absorption peak rather than the complex spectra of aggregates. These results indicate 310 
that designed mechanism is effective to detect METH.   311 
3.3 Optimization of sensing conditions 312 
The concentration of magnetic beads has a significant effect on experimental result.  313 
Excessive magnetic beads would cause waste, whereas insufficient magnetic beads 314 
would have a significant impact on the sensitivity of biosensors. In order to get the 315 
optimal concentration of magnetic beads, sensitivity of colorimetric approach in the 316 
presence of various MBs was also monitored, and the minimum SPR signal was 317 
optimized as the experimental condition. The optimized concentration of the MBs was 318 
determined with unchanged concentration of reporter probes and METH aptamer. As 319 
shown in Figure 2A, optimized MBs volume to achieve highest sensitivity was around 320 
1 μL.    321 
The hybridization time to form Au@Ag-dsDNA-MBs is an important parameter for 322 
the evaluation of colorimetric approach. Aptamers were added at the time point of 0 s, 323 
and spectra changes were observed. After addition of METH aptamer, the SPR peak 324 
signals of Au@Ag core-shell nanoparticles were recorded  for 110 min. Figure 2B 325 
shows that the intensity of SPR signal at 400 nm gradually decreased, and reached the 326 
minimum value in about 60 minutes. So the optimal reaction time is 60 minutes.  327 
SPR signal of Au@Ag nanoparticles decreased with increasing concentrations of 328 
METH aptamer (Figure 2C). Near complete quenching occurred at a concentration of 329 
60 nM. It should be noted that the excessive usage of METH aptamer could result in 330 
non-specific (i.e., no SPR enhancement) binding to the METH. As shown in Figure 331 
2C, at an aptamer concentration of 40 nM, METH prevented the quenching of the 332 
Au@Ag and SPR intensity of Au@Ag was almost fully recovered (up to 89.1%) to its 333 
initial value. Thus, 40 nM METH aptamer was chosen in our biosensor. 334 
3.4 Evaluation of sensing performance  335 
To determine the limit of detection (LOD) of our biosensors, different 336 
concentrations of METH from 0 to 200 nM were measured. Figure 3A shows the dose 337 
response of METH concentration with the colorimetric signal. As the METH 338 
concentrations increasing, the color of the supernatant solution turned from light 339 
yellow and to deep yellow (Figure 3C). The peak intensity of SPR signal is 340 
proportional to METH concentration, and the increasing METH concentration 341 
therefore leads to the deformation of Au@Ag-DNA-MBs sandwich structure. As is 342 
shown in Figure 3 B, the intensity of SPR signal (λmax=400 nm) increased with the 343 
increasing METH concentrations, and the linear range was determined from 0.5 nM to 344 
200 nM (R2=0.994). The LOD of the biosensor was determined to be 0.1 nM (3σ), 345 
which is much lower than 1000 ng mL-1 (6.7 μM), the threshold of positive METH 346 
detection in urine samples recommended by the National Institute on Drug Abuse of 347 
United States[52]. Shi et al. developed a aptamer biosensor for the detection of 348 
METH based on gold nanoparticles with a LOD at 0.82 μM [6]. Oghli et al. is able to 349 
electrochemically detect METH as low as 50 nM [53]. Compared to those sensors, 350 
our sensitivity is much improved and hold a great potential for routine screening of 351 
METH in urine samples 352 
To examine the selectivity of our biosensor, 8 non-target illicit drugs and/or 353 
metabolites (KET, NK, MOR, COC, CAT, MCAT, BZP and MDA) were tested. 354 
Figure 4A showed the responses of the colorimetric assay of METH (50 nM) and 355 
other drugs or metabolites (1 μM) under the optimized condition. METH led to an 356 
evident increase in the 400 nm value of the assay. In contrast, the absorbance signals 357 
associated with others compounds stayed at the same level as the blank. These signals 358 
were much lower than that in the presence of METH, despite the fact that METH 359 
concentration (50 nM) was much lower than other illicit drugs and/or metabolites. 360 
Furthermore, the enhancement in absorbance signals (relative to the blank) was not 361 
statistically significant among other drugs, These results demonstrate that binding 362 
affinity of METH to METH-aptamer were much stronger than that to all other illicit 363 
drugs, rendering the biosensor with high specificity toward METH. 364 
In order to further investigate the potential application of the proposed sensor, the 365 
assay was employed to detect METH in urine samples. The average recovery of 366 
METH in spiked urine sampled ranged from 83.1 and 90.5% (Table 1). The METH 367 
concentrations measured using HPLC-MS/MS (Figure 4B, black bar) ranged from 368 
19.2 to 131.8 nM. METH concentrations (Figure 4B, red bar) analyzed using our 369 
biosensor fell within the same range, but were slightly lower than the 370 
HPLC-MS/MS-derived concentrations, probably due to matrix effect [4, 54-56]. The 371 
variation of the measured valued from our sensors and HPLC-MS/MS are less than 372 
8.7%, indicating that our sensors have a clear potential for the detection of METH in 373 
real biological samples.  374 
3.5 Detection of cocaine with biosensors 375 
The sensing platform was also used to detect cocaine to explore the feasibility of 376 
this strategy as a generic platform. The probe sequences (Table. S1) are composed of 377 
an aptamer for COC and two probes that are complementary to the cocaine aptamer in 378 
different regions. As expected, in the absence of COC, the SPR signal of the 379 
supernatant was much lower than absolute SPR signal of Au@Ag; however, in the 380 
presence of COC, the strong SPR signal nearly equal to the absolute SPR signal of 381 
Au@Ag was observed (Figure S2).Optimal concentration of COC aptamer was found 382 
to be 30 nM, which is less than that of METH aptamer (Figure S3). Furthermore, a 383 
log-linear relationship (R2= 0.987) between COC concentration and absorbance signal 384 
intensity was also observed in a COC concentration range from 1.0 nM to 150 nM. 385 
The LOD was 0.5 nM (Figure S4) and comparable with previous report[23]. The 386 
promising results clearly demonstrates the versatility of the non-aggregation Au@Ag 387 
colorimetric strategy for illicit drug detection. 388 
4. Conclusion 389 
A novel, cost-effective and label-free biosensor based on the non-aggregation 390 
Au@Ag was developed for illicit drugs detection. The biosensor consisted of a 391 
reporter probe that is a specific single-stranded DNA sequences coated with Au@Ag, 392 
a capture probe conjugated with superparamagnetic magnetic beads, and an illicit 393 
drug-binding DNA aptamer. The DNA aptamer could hybridize with both RP and CP, 394 
generating Au@Ag-DNA magnetic beads (MBs) sandwich structure. When an 395 
external magnetic field is applied, Au@Ag-DNA-MB is removed from the solution, 396 
leading to decreased SPR intensity. In the presence of the illicit drugs, 397 
Au@Ag-DNA-MB sandwich structure cannot be formed due to higher affinity of the 398 
aptamer to illicit drug than that to complementary ssDNA. SPR intensity is correlated 399 
with the concentrations of target illicit drugs and this correlation can be used to 400 
quantify the target drugs. We demonstrated the novel sensing platform for the 401 
detection of illicit drugs such as METH and COC.  402 
  The optimized biosensor is able to detect as low as 0.1 nM METH with a linear 403 
range of from 0.5 nM to 200 nM, and other non-specific illicit drugs show a 404 
negligible interference. Recoveries of METH in the spiked urine samples were 405 
evaluated to be more than 83.1%. We also use HPLC-MS/MS to analyze urine 406 
samples for validation, and the results are in agreement. Furthermore, the developed 407 
sensing platform was used for the detection of cocaine with the cocaine-binding 408 
aptamer, which shows a promising result and the universality of our biosensors. In 409 
summary, we have demonstrated a generic biosensor based on non-aggregation 410 
Au@Ag core-shell structure for the sensitive detection of METH and COC, and it 411 
also has a potential for monitoring a wide spectrum of targets including illicit drugs 412 
by replacing respective DNA aptamer.  413 
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Figure: 561 
 562 
 563 
 564 
Scheme 1. The schematic representations of preparation of reporter probe (A) and 565 
capture probe (B) and colorimetric detection of illicit drug based on non-aggravation 566 
Au@Ag core-shell nanoparticles (C).  567 
 568 
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Figure 1. (A) Scanning electron microscope (SEM) image and (B) high resolution 579 
transmission emission microscope (HR-TEM) image of prepared Au@Ag core–shell 580 
nanoparticles. (C) SPR signal of Au@Ag and AuNPs. (D) UV-vis spectra of Au@Ag 581 
in the presence or absence of METH. The signal (A) is the absorbance of Au@Ag 582 
core-shell nanoparticles and error bars represent triplicate measurements (same for 583 
below). 584 
 585 
 586 
  587 
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(C)  
Figure 2. (A) SPR signal intensities at different MBs concentrations. The curve and 588 
UV-vis spectra (insert) of the supernatant at different concentrations of MBs. Under 589 
the same concentration of METH aptamer (40 nM), the sensitivity of assay positively 590 
correlated with variation of SPR peak intensity. (B) Hybridization reaction time of 591 
SPR signal intensity change at 400 nm with METH aptamer concentration of 40 nM. 592 
(C) SPR signal intensities of the Au@Ag (λmax=400 nm) in the presence of different 593 
concentrations of METH aptamer (Blue). Red bar is SPR signal intensity of the 594 
Au@Ag in the presence of METH (100 nM). The signal (ΔA) is expressed as the 595 
relative absorbance with respect to the blank and error bars represent three replicate 596 
measurements (same for below).  597 
 598 
 599 
(A)                                 (B) 600 
 601 
(C) 602 
Figure 3.  (A) UV-vis spectra of Au@Ag in the presence of different concentrations 603 
of METH (from bottom to up: 0, 0.5, 1, 5, 10, 20, 40, 60, 80, 100, 150, 200 nM). (B) 604 
SPR signal intensity (λmax=400 nm) at various METH concentrations (The inset shows 605 
the logarithm linear range concentration (0.5-200.0 nM). (C) Color change of the 606 
non-aggravation Au@Ag in the presence of METH. The METH concentrations in 607 
tubes from left to right were: 0, 5, 10, 50, and 100 nM.  608 
  
(A) (B) 
Figure 4. (A) Selectivity of the non-aggravation Au@Ag core-shell nanoparticles for 609 
METH detection. The METH concentration was 50 nM, while the concentration of 610 
other illicit drugs was 1 μM. From left to right: METH, KET, NK, MOR, COC, CAT, 611 
MCAT, BZP, MDA, and blank; (B) METH concentrations in human urine samples 612 
measured by the biosensor and (red) and by HPLC-MS/MS (black).   613 
 614 
  615 
Table 1. Recovery of METH in urines at three spiked METH concentration (10.0, 616 
50.0 and 100.0 nM), respectively. 617 
 618 
Spiked 
concentration 
(nM) 
The measured concentration 
of  METH (nM) 
Rate of 
standard recovery 
(%) 
 1 2 3 Average 1 2 3 Average 
0 19.23 18.74 18.85 18.94 - - - - 
10 27.35 27.75 26.64 27.25 81.2 90.1 77.9 83.1 
50 64.30 59.30 65.80 63.13 90.1 81.1 93.9 88.4 
100 113.40 109.50 105.30 109.40 94.2 90.8 86.5 90.5 
Supporting information 
A Novel Colorimetric Biosensor Based on non-Aggregated 
Au@Ag Core–Shell Nanoparticles for Methamphetamine and 
Cocaine Detection 
Kang Maoa, Zhugen Yangb, Junrong Lic, Xiaodong Zhouc Xiqing Lia,*and Jiming 
Huc 
 
a Laboratory for Earth Surface Processes, College of Urban and Environmental 
Sciences, Peking University, Beijing 100871, China 
b Division of Biomedical Engineering, School of Engineering, University of Glasgow, 
Oakfield Road, Glasgow G12 8LT, United Kingdom 
c Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of 
Education), College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 
430072, China 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Supplementary Materials 
 
Table S1. Oligonucleotide sequences used in the experiment 1. 
METH RP DNA 5'-GAGTCCCACTTGCAACCGT-SH-3’ 
COC RP DNA 5'-GGATTTATCCTTGTCTCCC-SH-3' 
METH CP DNA 5'-NH2-CCAAATTACCCAGCCTACC-3’ 
COC CP DNA 5'-NH2-TATCGACCCACTTCATTCG-3' 
METH aptamer 5′-ACGGTTGCAAGTGGGACTCTGGTAGGCTGGGTAATTTGG-3′ 
COC aptamer 5'-GGGAGACAAGGATAAATCCTTCAATGAAGTGGGTCGATA-3' 
 
 
  
 Figure S1. UV-vis spectra of Au@Ag in the presence or absence of COC.  
  
  
Figure S2.  SPR signal intensities of the Au@Ag (λmax=400 nm) in the presence of 
different concentrations of COC aptamer (Blue). Red bar is SPR signal intensity of 
the Au@Ag in the presence of COC (150 nM). The signal (△A) is expressed as the 
relative absorbance with respect to the blank and error bars represent three replicate 
measurements (same for below). 
 
  
  
(A)                                      (B) 
Figure S3.  (A) UV-vis spectra of Au@Ag at different concentrations of COC (0, 0.5, 
1, 5, 10, 20, 40, 60, 80, 100, and 150 nM). (B) SPR signal intensity (λmax=400 nm) at 
various METH concentrations (The inset shows the logarithm linear range 
concentration (1.0-150.0 nM). 
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